[EN] THIENOPYRIMIDINE-BASED INHIBITORS OF THE SRC FAMILY<br/>[FR] INHIBITEURS DE LA FAMILLE SRC A BASE DE THIENOPYRIMIDINE
申请人:UNIV TEXAS
公开号:WO2002057271A2
公开(公告)日:2002-07-25
Various thienopyrimidine-based analog compounds are able to selectively inhibit the Src family of tyrosine kinases. These compounds are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections. Embodiments of the invention are compounds of the formulae (A),(B) and (C)